1. Home
  2. HYFM vs QTTB Comparison

HYFM vs QTTB Comparison

Compare HYFM & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYFM
  • QTTB
  • Stock Information
  • Founded
  • HYFM 1977
  • QTTB 2015
  • Country
  • HYFM United States
  • QTTB United States
  • Employees
  • HYFM N/A
  • QTTB N/A
  • Industry
  • HYFM Industrial Machinery/Components
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HYFM Industrials
  • QTTB Health Care
  • Exchange
  • HYFM Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • HYFM 17.3M
  • QTTB 18.9M
  • IPO Year
  • HYFM 2020
  • QTTB N/A
  • Fundamental
  • Price
  • HYFM $4.37
  • QTTB $1.91
  • Analyst Decision
  • HYFM
  • QTTB Hold
  • Analyst Count
  • HYFM 0
  • QTTB 8
  • Target Price
  • HYFM N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • HYFM 7.7K
  • QTTB 169.5K
  • Earning Date
  • HYFM 08-12-2025
  • QTTB 08-06-2025
  • Dividend Yield
  • HYFM N/A
  • QTTB N/A
  • EPS Growth
  • HYFM N/A
  • QTTB N/A
  • EPS
  • HYFM N/A
  • QTTB N/A
  • Revenue
  • HYFM $161,102,000.00
  • QTTB N/A
  • Revenue This Year
  • HYFM $5.45
  • QTTB N/A
  • Revenue Next Year
  • HYFM $5.33
  • QTTB N/A
  • P/E Ratio
  • HYFM N/A
  • QTTB N/A
  • Revenue Growth
  • HYFM N/A
  • QTTB N/A
  • 52 Week Low
  • HYFM $1.50
  • QTTB $1.35
  • 52 Week High
  • HYFM $8.55
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • HYFM 51.00
  • QTTB 49.42
  • Support Level
  • HYFM $4.13
  • QTTB $1.73
  • Resistance Level
  • HYFM $4.73
  • QTTB $2.10
  • Average True Range (ATR)
  • HYFM 0.31
  • QTTB 0.19
  • MACD
  • HYFM -0.03
  • QTTB -0.00
  • Stochastic Oscillator
  • HYFM 45.18
  • QTTB 64.22

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: